News
Dr. Nestor Villamizar explains how robotic lung cancer surgery and innovative single-incision techniques may reduce pain and improve recovery. Blood protein signatures may predict ALS onset in genetically at-risk individuals years before symptoms appear. Researchers from the University of Miami Comprehensive Center for Brain Health shared 16 studies at AAIC 2026, highlighting advances in dementia treatment, blood-based biomarkers and early cognitive screening. A Sylvester-led study reveals how a rare mutation helps blood cancers evade BTK-targeted therapies and points toward strategies to prevent resistance.
The Latest Advances in Lung Cancer Surgery: Q and A with Dr. Nestor Villamizar
Blood Proteins May Predict When Genetically At-Risk People Develop ALS
University of Miami Researchers Showcase Advances in Dementia Detection, Treatment and Brain Health at AAIC 2026
Sylvester Comprehensive Cancer Center Study Reveals How Blood Cancers Outsmart BTK-Targeted Therapies
